September 30, 2023

September 29, 2023

October 1, 2023

Weekday

Saturday

Important events

SCIB1 in Melanoma Patients Receiving Pembrolizumab SCIB1-002

clinical trial

start time

August 19, 2019

end time

September 30, 2023 (4 years 1 month 11 days)

Single-stage Surgery Using the BI300 Implant

clinical trial

start time

August 1, 2019

end time

September 30, 2023 (4 years 1 month 29 days)

Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

clinical trial

start time

March 1, 2019

end time

September 30, 2023 (4 years 6 months 29 days)

Addressing Sleep Apnea Post-Stroke/TIA

clinical trial

start time

April 1, 2020

end time

September 30, 2023 (3 years 5 months 29 days)

Effectiveness and Implementation of eScreening in Post 9/11 Transition Programs

clinical trial

start time

March 1, 2021

end time

September 30, 2023 (2 years 6 months 29 days)

Environmental Localization Mapping and Guidance for Visual Prosthesis Users

clinical trial

start time

July 1, 2020

end time

September 30, 2023 (3 years 2 months 29 days)

Energy-optimized Symmetric Cryptography by Algebraic Duality Analysis

EU Funded (H2020) Research Project

start time

October 1, 2018

end time

September 30, 2023 (4 years 11 months 29 days)

Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma

clinical trial

start time

May 31, 2021

end time

September 30, 2023 (2 years 3 months 30 days)

Impacts of Subsidized Ridesharing on Drunk Driving, Alcohol Consumption, and Mobility

clinical trial

start time

October 1, 2021

end time

September 30, 2023 (1 year 11 months 29 days)

Effectiveness of CGMS vs. Self-monitoring Blood Glucose (SMBG) in Woman With Gestational Diabetes

clinical trial

start time

September 1, 2021

end time

September 30, 2023 (2 years 29 days)

A Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Heart Failure (LAPiS Study)

clinical trial

start time

August 19, 2021

end time

September 30, 2023 (2 years 1 month 11 days)

Evaluation of Efficacy and Tolerance of JOE on 4 to 11 Years Old Asthmatic Patients of GINA Grade 2,3 or 4.

clinical trial

start time

September 1, 2021

end time

September 30, 2023 (2 years 29 days)

Study of NMS-03592088 in Patients With Relapsed or Refractory AML or CMML

clinical trial

start time

April 3, 2019

end time

September 30, 2023 (4 years 5 months 27 days)

Acute Bronchiolitis in Infants and Allergic Asthma

clinical trial

start time

May 2, 2019

end time

September 30, 2023 (4 years 4 months 28 days)

Non-invasive Nerve Stimulation and Sleep

clinical trial

start time

January 3, 2020

end time

September 30, 2023 (3 years 8 months 27 days)

Více

Calendar

Year 2022

Year 2023

Year 2024

January 2023

2 3 4 5 6 7 8

9 10 11 12 13 14 15

16 17 18 19 20 21 22

23 24 25 26 27 28 29

30 31

February 2023

1 2 3 4 5

6 7 8 9 10 11 12

13 14 15 16 17 18 19

20 21 22 23 24 25 26

27 28

March 2023

1 2 3 4 5

6 7 8 9 10 11 12

13 14 15 16 17 18 19

20 21 22 23 24 25 26

27 28 29 30 31

April 2023

1 2

3 4 5 6 7 8 9

10 11 12 13 14 15 16

17 18 19 20 21 22 23

24 25 26 27 28 29 30

May 2023

1 2 3 4 5 6 7

8 9 10 11 12 13 14

15 16 17 18 19 20 21

22 23 24 25 26 27 28

29 30 31

June 2023

1 2 3 4

5 6 7 8 9 10 11

12 13 14 15 16 17 18

19 20 21 22 23 24 25

26 27 28 29 30

July 2023

1 2

3 4 5 6 7 8 9

10 11 12 13 14 15 16

17 18 19 20 21 22 23

24 25 26 27 28 29 30

August 2023

1 2 3 4 5 6

7 8 9 10 11 12 13

14 15 16 17 18 19 20

21 22 23 24 25 26 27

28 29 30 31

September 2023

1 2 3

4 5 6 7 8 9 10

11 12 13 14 15 16 17

18 19 20 21 22 23 24

25 26 27 28 29 30

October 2023

2 3 4 5 6 7 8

9 10 11 12 13 14 15

16 17 18 19 20 21 22

23 24 25 26 27 28 29

30 31

November 2023

1 2 3 4 5

6 7 8 9 10 11 12

13 14 15 16 17 18 19

20 21 22 23 24 25 26

27 28 29 30

December 2023

1 2 3

4 5 6 7 8 9 10

11 12 13 14 15 16 17

18 19 20 21 22 23 24

25 26 27 28 29 30 31